These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22198715)

  • 61. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.
    Jeong WI; Park O; Radaeva S; Gao B
    Hepatology; 2006 Dec; 44(6):1441-51. PubMed ID: 17133483
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
    Ai WL; Dong LY; Wang J; Li ZW; Wang X; Gao J; Wu Y; An W
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3780-3791. PubMed ID: 30251695
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of NKp46
    Haspeslagh E; van Helden MJ; Deswarte K; De Prijck S; van Moorleghem J; Boon L; Hammad H; Vivier E; Lambrecht BN
    EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29444897
    [TBL] [Abstract][Full Text] [Related]  

  • 64. NK cell development in bone marrow and liver: site matters.
    Gotthardt D; Prchal-Murphy M; Seillet C; Glasner A; Mandelboim O; Carotta S; Sexl V; Putz EM
    Genes Immun; 2014 Dec; 15(8):584-7. PubMed ID: 25319498
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H
    Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.
    Gao B; Radaeva S; Jeong WI
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):173-80. PubMed ID: 19072444
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C.
    Eisenhardt M; Glässner A; Krämer B; Körner C; Sibbing B; Kokordelis P; Nischalke HD; Sauerbruch T; Spengler U; Nattermann J
    PLoS One; 2012; 7(7):e38846. PubMed ID: 22792160
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research.
    Berhani O; Glasner A; Kahlon S; Duev-Cohen A; Yamin R; Horwitz E; Enk J; Moshel O; Varvak A; Porgador A; Jonjic S; Mandelboim O
    Eur J Immunol; 2019 Feb; 49(2):228-241. PubMed ID: 30536875
    [TBL] [Abstract][Full Text] [Related]  

  • 69. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.
    Alvarez-Breckenridge CA; Yu J; Price R; Wojton J; Pradarelli J; Mao H; Wei M; Wang Y; He S; Hardcastle J; Fernandez SA; Kaur B; Lawler SE; Vivier E; Mandelboim O; Moretta A; Caligiuri MA; Chiocca EA
    Nat Med; 2012 Dec; 18(12):1827-34. PubMed ID: 23178246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells.
    Foltz JA; Somanchi SS; Yang Y; Aquino-Lopez A; Bishop EE; Lee DA
    Front Immunol; 2016; 7():521. PubMed ID: 27933061
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
    Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T
    PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
    Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A
    J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Altered NKp46 Recognition and Elimination of Influenza B Viruses.
    Duev-Cohen A; Isaacson B; Berhani O; Charpak-Amikam Y; Friedman N; Drori Y; Mandelboim M; Mandelboim O
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33375516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.
    Satoh-Takayama N; Lesjean-Pottier S; Vieira P; Sawa S; Eberl G; Vosshenrich CA; Di Santo JP
    J Exp Med; 2010 Feb; 207(2):273-80. PubMed ID: 20142427
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
    PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
    Jarahian M; Fiedler M; Cohnen A; Djandji D; Hämmerling GJ; Gati C; Cerwenka A; Turner PC; Moyer RW; Watzl C; Hengel H; Momburg F
    PLoS Pathog; 2011 Aug; 7(8):e1002195. PubMed ID: 21901096
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in mice.
    Jiao J; Ooka K; Fey H; Fiel MI; Rahmman AH; Kojima K; Hoshida Y; Chen X; de Paula T; Vetter D; Sastre D; Lee KH; Lee Y; Bansal M; Friedman SL; Merad M; Aloman C
    J Hepatol; 2016 Aug; 65(2):344-353. PubMed ID: 27154062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
    Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
    BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.
    Walzer T; Bléry M; Chaix J; Fuseri N; Chasson L; Robbins SH; Jaeger S; André P; Gauthier L; Daniel L; Chemin K; Morel Y; Dalod M; Imbert J; Pierres M; Moretta A; Romagné F; Vivier E
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3384-9. PubMed ID: 17360655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.